Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

This guide explains how manufacturers manage device classification, FDA listing, EU MDR conformity assessment, CE marking, UDI, EUDAMED, technical documentation, and post-market controls to reduce registration delays, inspection findings, and global market-access risks throughout the product lifecycle.
Explore how pharma ERP software supports batch tracking, expiry management, data integrity, audit trails, and computer system validation across pharmaceutical distribution. The article also explains implementation risks, inspection evidence, and why software alone cannot guarantee GMP or GDP compliance.
Explore how PAS-X MES supports electronic batch records, production control, and data integrity in regulated pharmaceutical manufacturing. Learn which validation, access, audit trail, and lifecycle controls inspectors expect under 21 CFR Part 11 and EU GMP Annex 11.
Explore how Six Sigma software supports DMAIC, process capability analysis, root cause investigations, and CAPA effectiveness across regulated pharmaceutical operations. The article explains the controls quality teams need to create reliable data, defensible decisions, and inspection-ready evidence.
This article traces the evolution of pharmaceutical technology from controlled electronic records and process analytical technology to connected manufacturing, AI oversight, and Pharma 4.0, showing how digital systems reshaped GMP evidence, data integrity, and inspection readiness.
Explore how Pharma 4.0, smart manufacturing, IoT, artificial intelligence, and digital quality management reshape pharmaceutical operations. This guide explains the GMP controls, data integrity safeguards, validation evidence, and inspection-ready practices companies need for secure digital transformation.
Computer system validation in pharma helps companies protect electronic records, control GxP risks, and maintain compliance throughout the validation lifecycle. This guide explains risk-based testing, audit trail review, access control, change control, and inspection-ready evidence.
Discover how pharma quality systems based on ICH Q10 strengthen GMP compliance through CAPA, change management, quality risk management, and management review. Learn how an effective pharmaceutical quality system improves inspection readiness, prevents recurring failures, and supports continual improvement.
Explore how an electronic quality management system strengthens CAPA management, document control, audit trail review, and computerized system validation. This guide explains the core eQMS controls pharmaceutical companies need to maintain GMP compliance and improve inspection readiness.
This guide explains how an EMA risk management plan supports safety specification, additional pharmacovigilance activities, and effective risk minimisation measures. It also shows how lifecycle updates help teams manage important identified risks and maintain a positive benefit-risk balance.